Replies to post #180464 on Biotech Values

[linhdtu]

Well, if I were a speculator in Blue (which I am not currently), I wouldn't be too concerned about these sales, using the same line of reasoning I applied to enanta insiders' sales.

[DewDiligence]

(BLUE)—ALNY’s CEO, John Maraganore has a $130K gain from BLUE purchase in Jul 2014 public offering:

http://www.sec.gov/Archives/edgar/data/1180432/000120919114046959/xslF345X03/doc4.xml